Smith & Nephew Plc Director/PDMR Shareholding (0489A)
January 17 2024 - 10:05AM
UK Regulatory
TIDMSN.
RNS Number : 0489A
Smith & Nephew Plc
17 January 2024
SMITH & NEPHEW PLC
17 January 2024
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE
REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY
PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND
PERSONS CLOSELY ASSOCIATED WITH THEM.
On 17 January 2024, Smith & Nephew plc (the "Company")
received notification of the following transactions as detailed
below.
Reason for the notification
Initial notification Initial notification
/Amendment
------------------------------------------------
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
Name Smith & Nephew plc
------------------------------------------------
LEI 213800ZTMDN8S67S1H61
------------------------------------------------
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been conducted
Description of the Smith & Nephew plc SPON ADR American Depositary
financial instrument, Shares (ADS)
type of instrument
------------------------------------------------
Identification code ISIN: US83175M2052
------------------------------------------------
Nature of the transaction Purchase of American Depository Shares as
participants of the Company's Employee Stock
Purchase Plan
------------------------------------------------
Date of Transaction 2024 - 01 - 08 and 2024 - 01 - 09
------------------------------------------------
Place of Transaction New York Stock Exchange
------------------------------------------------
Name Director / Aggregated
(Position) PDMR Price ($) Volume information
Bradley Cannon
(President
Sports Medicine N/A Single
& ENT) PDMR 23.19 408.49634 Transaction
------------ ---------- ---------- -------------
Mizanu Kebede
(Chief Quality
& Regulatory N/A Single
Affairs Officer) PDMR 23.19 96.29754 Transaction
------------ ---------- ---------- -------------
Deepak Nath
(Chief Executive N/A Single
Officer) Director 23.19 408.49634 Transaction
------------ ---------- ---------- -------------
Paul Connolly
(President, N/A Single
Global Operations) PDMR 23.19 408.49634 Transaction
------------ ---------- ---------- -------------
Scott Schaffner
(President, N/A Single
Sports Medicine) PDMR 23.19 232.8564 Transaction
------------ ---------- ---------- -------------
*All figures in these columns are stated to 5 decimal places
where applicable.
Sarah Carne
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477410
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHFLFIELIIDLIS
(END) Dow Jones Newswires
January 17, 2024 10:05 ET (15:05 GMT)
Smith & Nephew (LSE:SN.)
Historical Stock Chart
From Apr 2024 to May 2024
Smith & Nephew (LSE:SN.)
Historical Stock Chart
From May 2023 to May 2024